No penalty for BlueCross NC after insurer lowers price for common HIV/AIDS drugs
A federal investigation into North Carolina's largest health insurer ended with no penalty after Blue Cross Blue Shield NC was accused of charging more for drugs, even generics, in a way that discriminates against some users.
Grace Hayba, WRAL health reporter